GlassScriptPhysician profile
Paul Cavallaro
NPI 1255710166
$19,722.67
in general payments reported to CMS, 2019-2025
12 companies · $17K in 2025
The $17K reported for 2025 was more than what 97% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $62.32 · 2023: $1,662 · 2024: $758 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,800 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,000 · Travel and Lodging: $4,773 · Food and Beverage: $3,087.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,800.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,000.00 |
| Travel and Lodging | $4,773.10 |
| Food and Beverage | $3,087.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $17,196.80 | 2023-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $1,094.89 | 2022-2025 | Eea, Signia, Aquamantys(Tm) |
| Virtual Incision Corporation | $264.00 | 2024 | Mira |
| Kerecis Limited | $245.89 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Thd America, INC. | $174.75 | 2024 | |
| Cook Biotech Incorporated | $173.19 | 2023 | Biodesign |
| Baxter Healthcare | $146.06 | 2025 | Floseal |
| Ethicon US, LLC | $142.61 | 2023-2025 | Contour, Enseal, Echelon Flex |
| Mimedx Group, INC. | $121.24 | 2024 | |
| Myriad Genetic Laboratories, INC. | $93.21 | 2023 | Myrisk |
| Caris Mpi, INC. | $45.10 | 2025 | Mi Cancer Seek |
| Axonics, INC. | $24.93 | 2024 | Bulkamid, Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Cavallaro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.